ScieGen Pharmaceuticals Inc. is voluntarily recalling certain lots of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms due to the presence of N-nitrosodiethylamin, or NDEA, a probable human carcinogen, in the drug substance.
from RTT - Biotech https://ift.tt/2ADelMj
via IFTTT
No comments:
Post a Comment